This is not the most recent version of the article. View current version (16 MAR 2011)

Intervention Protocol

Thrombelastography (TEG) or Thrombelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion

  1. Arash Afshari1,*,
  2. Anne Wikkelsø2,
  3. Jesper Brok3,
  4. Ann Merete Møller4,
  5. Jørn Wetterslev5

Editorial Group: Cochrane Anaesthesia Group

Published Online: 8 JUL 2009

DOI: 10.1002/14651858.CD007871


How to Cite

Afshari A, Wikkelsø A, Brok J, Møller AM, Wetterslev J. Thrombelastography (TEG) or Thrombelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD007871. DOI: 10.1002/14651858.CD007871.

Author Information

  1. 1

    Rigshospitalet, The Cochrane Anaesthesia Review Group & Copenhagen Trial Unit and Department of Paediatric and Obstetric Anaesthesia, Copenhagen, Denmark

  2. 2

    Herlev University Hospital, Department of Anaesthesiology, Herlev, Denmark

  3. 3

    Hvidovre Hospital, Paediatric Department, Hvidovre, Denmark

  4. 4

    Herlev University Hospital, The Cochrane Anaesthesia Review Group, Rigshospitalet & Department of Anaesthesiology, Herlev, Denmark

  5. 5

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

*Arash Afshari, The Cochrane Anaesthesia Review Group & Copenhagen Trial Unit and Department of Paediatric and Obstetric Anaesthesia, Rigshospitalet, Blegdamsvej 9, Afsnit 3342, rum 52, Copenhagen, 2100, Denmark. arriba.a@gmail.com. afshari@rocketmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 8 JUL 2009

SEARCH

This is not the most recent version of the article. View current version (16 MAR 2011)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

We will assess the benefits and harms of TEG/ROTEM guided transfusion in adults and children with massive transfusion. Furthermore, we will look at various outcomes, conduct subgroup and sensitivity analyses, examine the role of bias and apply trial sequential analyses (TSA) to examine the amount of evidence gathered so far.